The Inhibition of Tissue Plasminogen Activator and Urokinase-Induced Fibrinolysis by Some Natural Proteinase Inhibitors and by Plasma and Serum from Normal and Pregnant Subjects

References

• Aoki N., von Kaulla K. N. Dissimilarity of human vascular plasminogen activator and human urokinase. J. Lab. clin. Med. 1971; 78: 354
   PubMed Web of Science ®Google Scholar
• Astrup T., Nissen U. Urinary trypsin inhibitor (mingin): transformation into a new trypsin inhibitor by acid hydrolysis or by sialidase. Nature (Lond.) 1964; 203: 255
   PubMed Web of Science ®Google Scholar
• Astrup T., Stage A. A protease inhibitor in ox lung tissue. Acta chem. scand. 1956; 10: 617
   Google Scholar
• Astrup T., Thorsen S. The physiology of fibrinolysis. Med. Clin. N. Amer. 1972; 56: 153
   PubMed Web of Science ®Google Scholar
• Bachmann F., Fletcher A. P., Alkjaersig N., Sherry S. Partial purification and properties of the plasminogen activator from pig heart. Biochemistry 1964; 3: 1578
   PubMed Web of Science ®Google Scholar
• Bennett N. B. A method for the quantitative assay of inhibitor of plasminogen activation in human serum. Thrombos. Diathes. haemorrh. (Stuttg.) 1967; 17: 12
   PubMedGoogle Scholar
• Bennett N. B. Further studies on an inhibitor of plasminogen activation in human serum. Release of the inhibitor during coagulation and thrombus formation. Thrombos. Diathes. haemorrh. (Stuttg.) 1970; 23: 553
   PubMedGoogle Scholar
• Bonnar J., McNicol G. P., Douglas A. S. Fibrinolytic enzyme system and pregnancy. Brit. med. J. 1969; 3: 387
   PubMed Web of Science ®Google Scholar
• Brakman P. Fibrinolysis. A. Standardized Fibrin Plate Method and a Fibrinolytic Assay of Plasminogen. Scheltema and Holkema N. V., Amsterdam 1967
   Google Scholar
• Brakman P., Astrup T. Selective inhibition in human pregnancy blood of urokinase induced fibrinolysis. Scand. J. clin. Lab. Invest. 1963; 15: 603
   PubMed Web of Science ®Google Scholar
• Brakman P., Mohler E. R., Astrup T. A group of patients with impaired plasma fibrinolytic system and selective inhibition of tissue activator-induced fibrinolysis. Scand. J. Haemat. 1966; 3: 389
   PubMedGoogle Scholar
• Camiolo S. M., Thorsen S., Astrup T. Fibrinogenolysis and fibrinolysis with tissue plasminogen activator, urokinase, streptokinase-activated human globulin, and plasmin. Proc. Soc. exp. Biol. (N.Y.) 1971; 138: 277
   PubMed Web of Science ®Google Scholar
• Correll J. T., Sjoerdsma A. Inhibition of a human fibrinolytic system by normal and pathologic sera. Proc. Soc. exp. Biol. (N.Y.) 1962; 111: 274
   PubMed Web of Science ®Google Scholar
• Egeblad K. Effects on fibrin clot lysis of a trypsin inhibitor in peanuts (Arachis hypogaea). Thrombos. Diathes. haemorrh. (Stuttg.) 1967; 17: 31
   PubMedGoogle Scholar
• Egeblad K. Inhibitors of fibrinolysis. A comparative thrombelastographic study. Scand. J. clin. Lab. Invest. 1967; 20, Suppl. 98
   Web of Science ®Google Scholar
• Faarvang H. J. The excretion of trypsin inhibitor in urine during normal pregnancy. Acta endocr. (Kbh.) 1959; 31: 117
   PubMedGoogle Scholar
• Ganrot P. O., Bjerre B. α1-antitrypsin and α2-macroglobulin concentration in serum during pregnancy. Acta obstet. gynec. scand. 1967; 46: 126
   PubMed Web of Science ®Google Scholar
• Hedner U., Åstedt B. Studies on fibrinolytic inhibitors during pregnancy. Acta obstet. gynec. scand. 1971; 50: 99
   PubMed Web of Science ®Google Scholar
• Helle I. Fibrinolysis and coagulation. Effect of calcium and of coagulation on the lysis of fibrin clots. Scand. J. Haemat. 1968, Suppl. 4
   Google Scholar
• Hilden M., Amris C. J., Starup J. The haemostatic mechanism in oral contraception. Acta obstet. gynec. scand. 1967; 46: 562
   PubMed Web of Science ®Google Scholar
• Kawano T., Morimoto K., Uemura Y. Urokinase inhibitor in human placenta. Nature (Lond.) 1968; 217: 253
   PubMed Web of Science ®Google Scholar
• Kawano T., Uemura Y. Inhibition of tissue activator by urokinase inhibitor. Thrombos. Diathes. haemorrh. (Stuttg.) 1971; 25: 129
   PubMedGoogle Scholar
• Kok P., Astrup T. Isolation and purification of a tissue plasminogen activator and its comparison with urokinase. Biochemistry 1969; 8: 79
   PubMed Web of Science ®Google Scholar
• Kok P., Astrup T. Differentiation between plasminogen activators by means of epsilon-aminocaproic acid. Thrombos. Diathes. haemorrh. (Stuttg.) 1972; 27: 77
   PubMedGoogle Scholar
• Lauritsen O. S. The fibrinolytic enzyme system of human blood plasma in pregnancy. Scand. J. clin. Lab. Invest. 1969; 23: 191
   PubMed Web of Science ®Google Scholar
• Nilsson I. M., Kullander S. Coagulation and fibrinolytic studies during pregnancy. Acta obstet. gynec. scand. 1967; 46: 273
   PubMed Web of Science ®Google Scholar
• Paraskevas M., Nilsson I. M., Martinsson G. A method for determining serum inhibitors of plasminogen activation. Scand. J. clin. Lab. Invest. 1962; 14: 138
   PubMed Web of Science ®Google Scholar
• Shaper A. G., Path M. C., Kear J., Macintosh D. M., Kyobe J. The platelet count, platelet adhesiveness and aggregation and the mechanism of fibrinolytic inhibition in pregnancy and the puerperium. J. Obstet. Gynaec. Brit. Cwlth. 1968; 75: 433
   PubMedGoogle Scholar
• Thorsen S., Astrup T. Biphasic inhibition of urokinase-induced fibrinolysis by ϵ-aminocaproic acid; distinction from tissue plasminogen activator. Proc. Soc. exp. Biol. (N.Y.) 1969; 130: 811
   PubMed Web of Science ®Google Scholar
• Thorsen S., Brakman P., Astrup T. Influence of platelets on fibrinolysis: A critical review. Hematologic Reviews 1972; 3: 123
   Google Scholar
• Thorsen S., Glas-Greenwalt P., Astrup T. Differences in the binding to fibrin of urokinase and tissue plasminogen activator. Thrombos. Diathes. haemorrh. (Stuttg.) 1972; 28: 65
   PubMedGoogle Scholar
• Vogel R., Trautschold I., Werle E. Natural Proteinase Inhibitors. Academic Press., New York 1968
   Google Scholar
• White W. F., Barlow G. H., Mozen M. M. The isolation and characterization of plasminogen activators (urokinase) from human urine. Biochemistry 1966; 5: 2160
   PubMed Web of Science ®Google Scholar